Wuhan Pharmstar Pharmaceutical

Wuhan Pharmstar Pharmaceutical is a core subsidiary of Grand Pharmaceutical Group Limited, serving as a major R&D and manufacturing base for the group's pharmaceutical products. The company specializes in the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, with a strong focus on ophthalmology, cardiovascular, and cerebrovascular treatments. It is recognized as a leading supplier of emergency medicines and specialized preparations in China, including epinephrine and norepinephrine. Pharmstar operates multiple GMP-certified production lines and maintains a significant presence in both domestic and international markets through its extensive portfolio of chemical drugs and amino acid-based products.